LSP leads a USD 27.2 million Series B investment in Rotation Medical



Amsterdam, the Netherlands, 10 July 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces the fourth investment of its Health Economics Fund (LSP HEF) in Rotation Medical, a private US medical device company focused on developing new technologies to treat rotator cuff disease. LSP and existing investor New Enterprise Associates (NEA) co-led the financing, which also included new investor Pappas Ventures and others.  The financing round of USD 27.2 million will support the commercial launch and post-market clinical studies of the Rotation Medical rotator cuff system. A link to the Rotation Medical’s press release can be found here.
 
Contact
Dr. Rudy Dekeyser, Managing Partner LSP HEF
eqrxrlfre@yfcip.pbz
Tel: +31 (0)20 664 55 00
www.lspvc.com
 
« back to overview
Follow us

LSP leads a USD 27.2 million Series B investment in Rotation Medical



Amsterdam, the Netherlands, 10 July 2014. LSP (Life Sciences Partners), a leading European investor in health care, announces the fourth investment of its Health Economics Fund (LSP HEF) in Rotation Medical, a private US medical device company focused on developing new technologies to treat rotator cuff disease. LSP and existing investor New Enterprise Associates (NEA) co-led the financing, which also included new investor Pappas Ventures and others.  The financing round of USD 27.2 million will support the commercial launch and post-market clinical studies of the Rotation Medical rotator cuff system. A link to the Rotation Medical’s press release can be found here.
 
Contact
Dr. Rudy Dekeyser, Managing Partner LSP HEF
eqrxrlfre@yfcip.pbz
Tel: +31 (0)20 664 55 00
www.lspvc.com
 
« back to overview